CVS Health (CVS): Capital International Investors reduced its stake -12.2M shares
Capital International Investors reduced its stake in CVS Health, per its Q1 2026 13F.
- 15.4M
- Shares reported · -12.2M vs prior quarter
- 0.26%
- Disclosed portfolio weight
- $1.11B
- Reported value
- Holdings as of
- Mar 31, 2026
- Filed
- May 13, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 21, 2025CongressDisclosed partial sale of CVS — reported range $1,001 - $15,000
- Mar 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 18, 2026, the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health” or the “Company”) elected John E. Gallina to serve on the Board, effective March 19, 2026.”
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026CongressDisclosed purchase of CVS — reported range $1,001 - $15,000
- Mar 31, 2026Government · Federal Register proposed ruleFiduciary Duties in Selecting Designated Investment Alternatives
- Apr 1, 2026Federal contract · $204K obligatedDepartment of Veterans Affairs awarded CVS Health: $204K obligated to date
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 6, 2026Company filing · Form 8-K · ResultsReported its results
- May 8, 2026Insider · 6 days before an 8-KOfficer sold ~$6.23M of CVS shares in the open market
What came next
- May 14, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 14, 2026, CVS Health Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved the 2026 Incentive Compensation Plan of CVS Health Corporation (the “2026 ICP”), which replaces the Company’s expiring 2017 Incentive Compensation Plan.”
- May 19, 2026Insider · 1 personInsiders: 2 sales (~$187.3M)
- May 20, 2026Insider · 1 personInsiders: 4 sales (~$95.5M)
- May 21, 2026Insider · 1 personInsiders: 2 sales (~$69.9M)
- Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 13, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On August 13, 2026, Larry M. Robbins notified the Board of Directors (the “Board”) of CVS Health Corporation (the “Company”) of his resignation from the Board, effective immediately.”
- Aug 13, 20265% stakeDodge & Cox reported a passive stake (13G) of 3.9%
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for CVS Health
For CVS Health, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CVS page.
How this filing works
Explore the data
Common questions
What does this filing report about CVS Health (CVS) stock?
Capital International Investors reduced its stake in CVS Health, per its Q1 2026 13F. Now 15.4M shares, $1.11B reported value, 0.26% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2026. Filed: May 13, 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about CVS Health recently?
For CVS Health, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the CVS page.
Does this mean CVS stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at CVS Health
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 6, 2026
- USAspending.gov award recordSep 25, 2026
- USAspending.gov award recordAug 17, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its CVS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
